12: An Updated Analysis of Survival Endpoints for Ascende-Rt, A Randomized Trial Comparing A Low-Dose-Rate Brachytherapy Boost to A Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer